Related Experiment Video
Updated: Jun 11, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
[Characteristics of anemia in patients with oncogynecological pathology]
Abstract:
The aim of the study was to elucidate complex changes in Hgb, erythrocyte count, ESR, and MCH in patients with oncogynecological problems depending on the affected organ and stage of the disease. A total of 340 women were examined in the oncogynecological department of No 40 city hospital, Moscow, from 2005 to 2008. The group included 132 patients with gynecological, 177 with oncogynecological and 31 with oncologycal diseases. A common coefficient was derived to characterize functional activity of erythrocytes The notion of intoxication effect coefficient (IC) is introduced and substantiated. Erythrocyte IC is shown to be useful for the comparison of groups with gynecological and oncogynecological problems. It decreases in patients with a tumorigenic process depending on its phase.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Chronic Kidney Disease II: Clinical Manifestations
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cirrhosis I: Introduction